ASAFOETIDA (HOMEOLAB USA INC.)


Welcome to the PulseAid listing for the ASAFOETIDA drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: HOMEOLAB USA INC.
NON-PROPRIETARY NAME: ASAFOETIDA
SUBSTANCE NAME: ASAFETIDA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00


ASAFOETIDA HUMAN OTC DRUG Details:

Item DescriptionASAFOETIDA from HOMEOLAB USA INC.
LABELER NAME: HOMEOLAB USA INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 1995-10-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60512-6522_a09236ca-b811-4f5e-a8a5-7144af001b79
PRODUCT NDC: 60512-6522
APPLICATION NUMBER:

Other ASAFETIDA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
HOMEOLAB USA INC.ASAFOETIDA
Humco Holding Group, IncAsafetida
Natural Health SupplyFlatulence
Rxhomeo Private Limited d.b.a. Rxhomeo, IncASAFOETIDA